Tubulin tyrosine ligase (TTL) catalyzes the post-translational C-terminal tyrosination of a-tubulin. Tyrosination regulates recruitment of microtubule-interacting proteins. TTL is essential. Its loss causes morphogenic abnormalities and is associated with cancers of poor prognosis. We present the first crystal structure of TTL (from Xenopus tropicalis), defining the structural scaffold upon which the diverse TTL-like family of tubulin-modifying enzymes is built. TTL recognizes tubulin using a bipartite strategy. It engages the tubulin tail through low-affinity, high-specificity interactions, and co-opts what is otherwise a homo-oligomerization interface in structurally related ATP grasp-fold enzymes to form a tight hetero-oligomeric complex with the tubulin body. Smallangle X-ray scattering and functional analyses reveal that TTL forms an elongated complex with the tubulin dimer and prevents its incorporation into microtubules by capping the tubulin longitudinal interface, possibly modulating the partition of tubulin between monomeric and polymeric forms.
a r t i c l e s TTL adds a C-terminal tyrosine to α-tubulin as part of a tyrosinationdetyrosination cycle present in most eukaryotic cells. α-tubulin is synthesized with a C-terminal tyrosine that can be removed by α-tubulin tyrosine carboxypeptidase, leading to detyrosinated tubulin with a C-terminal glutamate (Glu-tubulin). Acting on the αβ-tubulin heterodimer, TTL restores the C-terminal tyrosine, producing tyrosinated Tyr-tubulin. TTL is essential for development and cellular function. TTL-null mice die within an hour after birth because of disorganized neuronal networks 1, 2 and suppression of TTL expression provides a marked selective advantage for tumor growth 3 . TTL suppression leads to formation of microtentacles rich in Glu-tubulin that penetrate endothelial layers to facilitate reattachment of circulating tumor cells during metastasis 4 . TTL suppression is correlated with poor prognosis in neuroblastoma, breast and prostate cancer patients 5 .
The tyrosination-detyrosination cycle affects microtubule dynamics in cells through differential recruitment of cytoskeletal regulators. The unstructured α-tubulin tail lies on the outside of the microtubule, close to binding sites of motors and microtubule-associated proteins 6 . Studies using antibodies to Tyr-or Glu-tubulin have shown that the cellular distribution and stability of these microtubule populations is markedly different 7 . Interphase microtubules are mostly tyrosinated and spindle microtubules are detyrosinated; microtubules in dendrites are enriched in Tyr-tubulin, whereas microtubules in axons are enriched in Glu-tubulin [8] [9] [10] [11] [12] . Detyrosinated microtubules persist as long as 16 h, whereas tyrosinated microtubules turn over in only 3-5 min 7 . Mitotic centromere-associated kinesin (MCAK) preferentially binds and depolymerizes Tyr-microtubules over Glu-microtubules, thus contributing to their differential stability in the cell 13 . Tyrosination also affects microtubule end dynamics by acting as a localization signal for microtubule plus end-binding proteins cytoplasmic linker protein-170 (CLIP-170) and p150Glued 14 . These proteins use their cytoskeleton-associated protein glycine-rich (Cap-Gly) domains to recognize a composite binding site formed by the tyrosinated α-tubulin tail and the end-binding protein EB1 (refs. 15,16) . Consistent with the importance of tyrosination in recruitment of microtubule plus-end tracking proteins, TTL is needed in migrating fibroblasts for robust polarization of the microtubule cytoskeleton 14 . Tyrosination can also act as a negative cue. In neurons, the kinesin-1 KIF5 targets only to the axon (rich in Glu-microtubules) and not dendrites (rich in Tyr-microtubules) 17, 18 by sensing the presence of the C-terminal tyrosine on tubulin. Mutation of KIF5 or TTL depletion breaks the asymmetric distribution of this kinesin, allowing it to enter both axon and dendrites 17 .
Tubulin tyrosination was the first tubulin-specific post-translational modification reported 19, 20 , with a plethora of evolutionarily conserved tubulin modifications subsequently discovered 21 . TTL was first isolated from brain extracts in 1977 (refs. 22-24) . The tyrosinationdetyrosination cycle has been characterized in a wide range of eukaryotes including trypanosomes, nematodes and humans 11, [25] [26] [27] , and TTL has a marked degree of sequence conservation from echinoderms to humans (Supplementary Fig. 1 ), exhibiting >96% identity among mammalian orthologs.
Tubulin is also subject to polyglutamylation and polyglycylation. These abundant and evolutionarily conserved post-translational modifications lead to addition of glutamate or glycine chains of variable lengths to the α-or β-tubulin C-terminal tails. Although the modifications themselves have been known for decades, only recently has it become clear that the enzymes responsible are evolutionarily a r t i c l e s related to TTL 28, 29 , probably sharing a similar structure and enzymatic mechanism. The polyglutamylases and polyglycylases now form the TTL-like (TTLL) family [30] [31] [32] [33] .
Although the cell biological role of TTL and the tyrosinationdetyrosination cycle have been extensively studied, the molecular mechanism of TTL action remains to be resolved. To this end, we determined the first crystal structure of TTL, in its apo, ATP-and ADP-bound states, thus defining the scaffold upon which the diversity of recognition for the TTLL family evolved. Using analytical ultracentrifugation, small-angle X-ray scattering (SAXS) and functional analyses, we show that TTL uses a conserved, positively charged surface to recognize the α-tubulin tail and forms an elongated complex with the αβ-tubulin heterodimer. TTL caps the tubulin heterodimer on the interface where tubulin would make longitudinal interactions within the microtubule lattice, thereby preventing its incorporation into microtubules. Consistent with this, TTL inhibits tubulin polymerization in vitro, and TTL overexpression decreases microtubule growth in vivo, suggesting that in addition to modifying the α-tubulin tail, TTL could also influence the partition of tubulin between monomeric and polymeric forms in cells.
RESULTS

Structural overview
Xenopus tropicalis TTL was expressed in Escherichia coli and purified to homogeneity. X. tropicalis TTL is 81% identical to human TTL (Supplementary Fig. 1 ) and it tyrosinates bovine brain tubulin in vitro with activity comparable to that of the murine enzyme (data not shown). Of 386 TTL crystals tested, 95% were severely split and did not provide useful data. The structure of apo-TTL was determined by combining low-resolution phases from Ta 6 Br 12 soaks with phases from a two-wavelength SeMet MAD experiment. The 2.5 Å-refined model of apo-TTL has R free of 29.8% (Table 1 and Methods). The structures of TTL bound to the slowly hydrolyzable ATP analog AMPPNP and to ADP (at resolutions of 2.5 Å and 2.9 Å, respectively) were solved by molecular replacement and refined to R free of 28.5% and 31.3%, respectively (Table 1, Methods and Supplementary  Fig. 2 , showing experimental map and superposition of apo, ADP and AMPPNP structures).
TTL is elongated (maximum dimensions, 70 × 40 Å 2 ; Fig. 1a ) and comprises three domains: an N-terminal domain (residues 1-71), a central domain (residues 72-188) and a C-terminal domain (residues 189-377). The N-terminal domain adopts an α/β fold comprised of a four-stranded parallel β-sheet flanked on one side by helix α1, and on the other by irregular segments that include two 3 10 -helices. The central domain is formed by a four-stranded antiparallel β-sheet flanked by helices α3 and α4 on one face and the C-terminal domain on the other. Helix α2 lies on the β-sheet edge, contacting both the N-and C-terminal domains. The C-terminal domain is formed by an elongated antiparallel β-sheet (strands β11, β9, β12 and β13). The long strand β12 reaches into the N-terminal domain and bridges the β-sheets from the N-and C-terminal domains to form a continuous curved β-sheet ( Fig. 1 and Supplementary Fig. 2b ). The C-terminal domain β-sheet underlies the active site and is surrounded by three helices, with long helix α6 serving as a 'brace' that makes stabilizing interactions across strands β11-β13. Both the central and C-terminal domains contribute to nucleotide coordination, cradling the nucleotide at their interface. There are no major conformational differences between the apo and nucleotide-bound structures. The central domain has some conformational plasticity, rotating ~3° between the apo (or ADP) and AMPPNP crystal forms ( Supplementary  Fig. 2 ). Structure-based sequence alignments of TTLs ranging from the sea urchin Strongylocentrotus purpuratus to human demonstrate the high degree of conservation of these enzymes, both within their hydrophobic cores and in surface-exposed residues (Fig. 1b,c and Supplementary Fig. 1 ). Thus, the structure of X. tropicalis TTL is representative of that of all known TTLs. Despite having only 9% overall sequence identity, the fold of TTL closely resembles that of d-alanine:d-alanine ligase (PDBeFold Z score = 6.1 (refs. 34,35) ), a member of the ATP-grasp superfamily, which includes enzymes of diverse specificities that catalyze the ATP-dependent ligation of a carboxylate-containing molecule to an amine or a thiol 36 . Their fold is characterized by two α/β domains (the central and C-terminal domains in TTL) that 'grasp' the ATP between them. Although the overall fold of the TTL N-terminal domain is similar to the corresponding domain in a r t i c l e s d-alanine:d-alanine ligase, the structural equivalencies are strongest for the central and C-terminal domains (r.m.s. deviation of 3.1 Å over 219 residues). The TTL fold also resembles that of glutathione S-transferase (GST), another ATP-grasp enzyme, as has been proposed 29 . However, our crystal structure shows that TTL and GST are sufficiently divergent that the secondary structure prediction of TTL based on the latter has several inaccuracies 29, 30 . Unique among known ATP-grasp family structures is the continuation of hydrogen bonding between strands β4 and β12 (from the N-and C-terminal domains, respectively), which gives rise to a continuous nine-stranded β-sheet in TTL ( Fig. 1 and Supplementary Fig. 2b ).
In other ATP-grasp superfamily members, the N-and C-terminal domain β-sheets are disjointed.
A versatile common scaffold for TTL and TTLLs
Mapping of sequence conservation from a multiple sequence alignment of TTL and TTLL polyglutamylases and polyglycylases onto the TTL crystal structure reveals how the TTL scaffold supported the expansion of the repertoire of tubulin post-translational modification enzymes. The core secondary structural elements in the three domains are conserved, and the TTL-specific central elongated β-sheet underlying the active site is most highly conserved (Fig. 1c) . This indicates that TTL and TTLL family members share a similar core architecture. The conservation pattern of surface residues among members of the TTL and TTLL families with divergent specificities (TTL, TTLL3-TTLL7 and TTLL10) indicates that only residues immediately adjacent to the ATP-binding site are invariant, whereas the rest of the molecular surface evolved to accommodate different recognition specificities (Fig. 1d) . Notably, when comparing family members with similar specificities, putative common platforms of substrate recognition emerge. For example, TTL and TTLL5, both enzymes specific for the α-tubulin tail 30 , share an elongated conserved patch extending from the ATP-binding site toward the N-terminal domain (Fig. 1e) . Mutations of residues in this patch impaired α-tubulin tail recognition by TTL (see below), suggesting a shared α-tubulin tail-binding surface.
Active site architecture ATP is wedged against a loop connecting the central and C-terminal domains (residues 184-198; Fig. 2a and Supplementary Fig. 2c ). The phenyl group of Tyr185 interacts edge on with the base of ATP, which is sandwiched between conserved hydrophobic residues (Met320 and Ile148) and makes hydrogen bonds with conserved functional groups in the central domain (Lys198, Lys184 and Lys150; Figs. 1 and 2a-c).
The α-, β-and γ-phosphates make electrostatic interactions with the side chains of invariant Lys150, Lys74 and Arg220, respectively, and the β-and γ-phosphates are bridged by a magnesium ion also coordinated by Glu331 (Fig. 2a) . Consistent with the essential role of ATP for TTL activity 22 , mutation of residues involved in nucleotide binding (Y185A and K198A D200A) abolished tyrosination activity (assayed with an α-tail peptide substrate; Fig. 2d and Supplementary  Fig. 3 ). Glu331 is invariant in all TTLs and TTLLs (and in ATP-grasp enzymes 30 ); its mutation inactivated TTL (Fig. 2d) . The conservation of active site architectures between TTL and ATP-dependent ligases like d-alanine:d-alanine ligase, suggests that TTL and TTLLs use a catalytic mechanism similar to that of these ligases ( Supplementary Fig. 4 ).
Molecular determinants of a-tubulin tail recognition
The TTL electrostatic surface has a conserved, positively charged stripe running from the ATP-binding site to the N-terminal domain (Fig. 2b) . This is probably a region of interaction with the negatively charged α-tubulin tail. In contrast, the dorsal surface of TTL is negatively charged and less conserved, and thus is unlikely a r t i c l e s to interact with the anionic tubulin tail (Fig. 2c) . We carried out structure-guided mutagenesis of conserved surface and active site residues and tyrosination assays using an α-tail peptide as substrate for the purified mutant TTLs (Methods and Supplementary Fig. 3 ).
The guanidinium group of Arg202 is situated 6.9 Å from the γ-phosphate and is part of a positively charged pocket ideal for binding the C-terminal glutamate of the α-tubulin tail (Fig. 2a,b) . TTL and TTLLs catalyze the addition of an amino acid to a glutamate ( Supplementary Fig. 4 ). Arg202 is invariant in all TTL and TTLLs ( Fig. 1d and Supplementary Fig. 1 ) and its mutation inactivated TTL (Fig. 2d) . The mobile loop connecting β11 and α5 (residues 230-260) is near the active site and contains two highly conserved motifs ( Fig. 3a and Supplementary Fig. 1 
). The first (HL(T/C)N) is common to all TTLs and TTLLs, whereas the second ((Y/F)G(R/K)YEE)
is unique to the TTLs. The structurally equivalent loop is used in d-alanine:d-alanine for substrate recognition 37 . This loop exhibits no conservation within the broader ATP-grasp family, consistent with its specialization for substrate binding. Deletion of residues in this loop (∆239-243 or ∆237-249) or mutation of residues in the TTL-specific motif (Y253A R255A Y256A E257A) inactivated TTL (Fig. 2d) , but did not abolish tubulin binding, supporting its essential role in recognizing the tubulin tail. Continuing toward the interface between the central and N-terminal domains, invariant Arg73 and conserved Lys70 are important in α-tubulin peptide recognition, as the mutation R73E or the double mutation K70A R73A leads to 99.4% and 98% lower tyrosination rate compared with wild type, respectively (Fig. 2d) . Notably, TTL contains a predicted cAMP-dependent kinase serine phosphorylation site (RKAS) 28 at Ser76 and adjacent to Arg73, suggesting a possible mode of TTL regulation. In the N-terminal domain, mutation of conserved residues Arg44 and Arg46 in the loop connecting β3 and 3 10 1 led to >99.8% lower activity compared with wild type (Fig. 2d) . The charge reversal mutant R46E had a more modest reduction in activity, underscoring that Arg44 is the more critical residue in α-tail recognition. Notably, Arg44 is conserved in TTLL5 (an α-tubulinspecific glutamyl ligase) but not in other TTLLs (Fig. 1d,e) , suggesting that it is important for α-tubulin tail recognition in that case also. The structurally equivalent loop in d-alanine:d-alanine ligase and other ATP-grasp proteins partially occludes the active site and is also used for substrate binding 37, 38 ; however, the loop in TTL is considerably shorter than in other ATP-grasp proteins, consistent with TTL binding to a larger ligand at the interface between the N-and C-terminal domains, compared with the small substrates typical for ATP-grasp enzymes (that is, d-alanine and glutathione). Mutation of the conserved positive patch residues at the tip of the N-terminal domain (R29A K31A R32A or H54E; Figs. 1b and 2b,c) had a small effect on tyrosination, indicating that they do not determine α-tail recognition.
Tubulin recognition by a co-opted oligomerization interface
We next examined the effects of our structure-guided mutations on tubulin tyrosination. We were not surprised to find that mutations that strongly impaired activity with the α-tail peptide (K70A R73A, R73E, R44A R46A, Y253A R255A Y256A E257A) also did so with tubulin (Fig. 3a,b) . Deletion of the mobile loop connecting β11 and α5 (TTL ∆237-249) inactivated TTL both with peptide and with tubulin substrate. This mutant also had modestly lower tubulin-binding affinity than wild type as assayed by gel filtration (Fig. 4a-c) . Nearby conserved Asp165 and Glu168 in the central domain are also important for tubulin recognition, as their mutation led to 75% lower tubulin tyrosination compared with wild type, whereas the effect on peptide tyrosination was small (Fig. 3b) . The central domain has the highest B-factors in the TTL structures, suggesting that its plasticity might be important for accommodating tubulin. The charge reversal mutant of invariant Arg66, which had robust activity with the α-tail peptide (Fig. 2d) , had very low activity with tubulin (~90% reduction; Fig. 3 ). Size-exclusion chromatography showed that this mutant was defective in tubulin binding (Fig. 4d) , suggesting that the tubulin-binding interface lies close to the junction of the central and N-terminal domains. Notably, a TTL mutant missing the disordered loop between β5 and α3 (∆104-119) in the central domain showed 30% greater activity with the peptide, but >90% decrease in activity with tubulin, compared with wild type (Fig. 3b) . Unlike the R66E mutant, the ∆104-119 mutant bound tubulin (Fig. 4e) , suggesting that residues connecting the β5 and α3 structural elements might have a role in the release of tubulin from the TTL-tubulin complex. Consistent with the lack of involvement of the dorsal face in α-tail or tubulin recognition, the charge reversal mutation of conserved Lys376 (Fig. 2c ) had no effect on tyrosination activity (Fig. 3b) .
Mutations on the TTL molecular surface that affect tubulin tyrosination, but not peptide tyrosination, cluster on the upper quadrant of the molecule, in the C-terminal and central domains or at the N-terminal and central domain junction (Fig. 3a) . Notably, all hitherto characterized ATP-grasp superfamily members (for example, d-alanine:d-alanine ligase 37 , GST 38 , synapsin 39 and lysine biosynthesis enzyme LysX 40 ), are either dimers or tetramers and use their equivalent surfaces for oligomerization. TTL is monomeric in our crystals, and analytical ultracentrifugation indicated that it is monomeric in solution. The sedimentation coefficient distribution (c(s)) Supplementary Fig. 3 ). VDSVEGEGEEEGEE is an optimal TTL peptide substrate 42 . Error bars indicate s.e.m. and are frequently smaller than the symbols.
a r t i c l e s of TTL showed a single peak representing the TTL monomer with an s value of 3.36 ( Fig. 4f) and a corresponding molecular mass of 42,696 Da, in agreement with the mass predicted for monomeric TTL (43,686 Da). Thus, the homo-oligomerization interface of ATPgrasp enzymes has evolved in TTL to recognize the tubulin dimer, a substrate substantially larger than those of typical ATP-grasp ligases. TTL, which has uniquely evolved to be a monomer, is unstable without tubulin 22, 41 , which completes its oligomerization interface.
The TTL-tubulin complex in solution
Our ultracentrifugation experiments demonstrate that purified TTL forms a 1:1 complex with tubulin (the calculated molecular mass of 141,974 Da is in agreement with the predicted mass of 143,584 Da; Fig. 4g and Methods), consistent with sucrose gradient analysis of endogenous TTL-tubulin complexes 24 . The c(s) distributions obtained with protein mixtures with 1:1 tubulin/TTL ratios at increasing concentrations showed two peaks, a small s value peak representing free TTL, with the area of the peak decreasing with increasing protein concentration, and a high s value peak representing the position of the tubulin-TTL complex reaction boundary. By analyzing the shift in position of the complex peak with increasing protein concentration, the affinity constant of TTL for tubulin was determined to be ~1 µM ( Fig. 4g and Methods). Isolated α-tubulin tail peptide bound to TTL with low affinity (K d ≈ 144 µM; Methods) when compared with tubulin, and the specific activity of TTL with this peptide is 98% lower than with tubulin 42 , indicating that the enzyme makes important contacts with the tubulin dimer in addition to the α-tail. The low binding affinity for the α-tail peptide explains the earlier observation that TTL is inefficient at modifying α-tubulin in microtubules 43 despite the fact that the flexible tail is exposed on the microtubule surface. To further characterize the TTL-tubulin complex, we carried out SAXS experiments. The SAXS data show that the TTL-tubulin complex has a considerably larger maximal dimension (D max ) than either TTL or tubulin alone, at 165 ± 3 Å versus 72 ± 5 Å or 95 Å, respectively ( Fig. 5a and Supplementary Fig. 5 ; in the case of tubulin, the D max was determined from the known electron crystal structure; PDB 1JFF 44 ). The elongated nature of the complex is consistent with our sedimentation velocity data, which indicates that the shape of the TTL-tubulin complex is approximated by a prolate ellipsoid with an aspect ratio of 3.8. We benchmarked our analysis by determining through analytical ultracentrifugation the aspect ratio for the tubulin heterodimer alone. This led to an aspect ratio of 2.2, in agreement with the known tubulin structure 44 . Comparison of the calculated pair-distribution (P(r)) function for tubulin and the experimental P(r) for the TTL-tubulin complex also showed that in addition to being more elongated, the complex is asymmetric as the function is relatively skewed (Fig. 5a) . We used SAXS data to generate low-resolution ab initio models of three-dimensional arrangements of scattering centers that provide the shape of the molecular envelope for the TTL-tubulin complex ( Fig. 5b and Methods). We carried out 15 ab initio simulations and the resulting models were aligned, averaged and filtered on the basis of occupancy (Fig. 5c,d and Methods). The filtered structure of the TTL-tubulin complex is a deformed prolate ellipsoid with a narrower side. The wider section has dimensions consistent with those of the αβ-tubulin heterodimer (95 × 50 Å 2 ). The remaining volume is consistent with the TTL molecular envelope, with the N-terminal domain lying at the edge of the complex and the central and C-terminal domains contacting the tubulin body. This proposed model is consistent with our mutagenesis data showing that mutations at the tip of the N-terminal domain did not affect tyrosination, but mutations in the central and C-terminal domains and in the N-terminal and central domains junction did (Figs. 3 and 4) .
Given the symmetric nature of the tubulin dimer and the limited resolution of the SAXS reconstruction, it is not possible to unequivocally position the tubulin heterodimer in the reconstruction and establish which tubulin protomer is recognized by TTL. However, the length of the α-tubulin tail and the substrate requirements of TTL support a model in which the major recognition interface is on α-tubulin. The last 11 residues in the α-tubulin tail are disordered in the tubulin structure 44 . Assuming that these residues are in a completely extended conformation (leading to a maximum length of Fig. 5e) , the distance the α-tail would have to span if TTL were to recognize mainly the β and not the α-tubulin protomer is too long for it to reach the active site at the center of the TTL volume (Fig. 5f) . Moreover, solution NMR and molecular dynamics studies show that the α-tail is not fully extended, but adopts a slightly helical conformation with a span of ~29 Å (ref. 45 ). Thus, without large conformational changes upon binding, TTL probably recognizes α-tubulin on the surface that would form the longitudinal interface in the context of the microtubule. We tested this model by carrying out tubulin tyrosination assays with antibodies that recognize various αβ-tubulin dimer epitopes (Supplementary Fig. 6 ). Antibodies to an epitope in β-tubulin at the longitudinal interface or in the H11-H12 C-terminal helices did not inhibit tyrosination, whereas an antibody to the α-tubulin tail inhibited the reaction robustly. Moreover, an antibody to an epitope on α-tubulin (residues 65-97) near the αβ protomer interface that lies close to the interface between TTL and tubulin in our model also inhibited tyrosination ( Fig. 5c and Supplementary Fig. 6 ). The engagement of the tubulin dimer through α-tubulin with minimal β-tubulin contacts, if any, is unexpected, as TTL was proposed to have a β-tubulin-binding site on the basis of cross-linking studies, and this interaction was proposed to be a determining factor for the high specificity of TTLs for the tubulin heterodimer 46 . Our data do not exclude an interaction between TTL and β-tubulin; however, they support a model in which the major interaction surface is not through β-tubulin. The extensive interaction surface with the tubulin dimer explains the high degree of specificity TTL has for tubulin and the earlier observation that TTL interacts with monomeric tubulin and not microtubules 20, 43 , as the TTL-binding surface is partially buried upon microtubule assembly.
TTL inhibits tubulin polymerization in vitro and in vivo
On the basis of our SAXS reconstruction, TTL should inhibit tubulin polymerization as it caps the longitudinal microtubule a r t i c l e s
interface of tubulin. We tested this by examining the effects of TTL on the spontaneous polymerization of tubulin in vitro ( Fig. 6a and Supplementary Methods). Addition of purified TTL to a solution containing 20 µM tubulin led to dose-dependent reduction of polymerization. When added in 1:1 molar ratio to tubulin, TTL effectively prevented microtubule assembly, consistent with its ability to bind and prevent the incorporation of tubulin into the microtubule lattice (Fig. 6a) .
To better understand the nature of the TTL-tubulin interaction, we examined the effects of our structure-guided surface mutants on tubulin polymerization (Fig. 6b) . TTL mutants affected in α-tail recognition and/or tubulin heterodimer recognition were impaired in inhibiting tubulin polymerization. Notably, mutation of Arg66 at the junction between the central and N-terminal domains did not inhibit microtubule polymerization, consistent with its loss in tubulin binding despite its ability to recognize the α-tail peptide (Figs. 2d and  4d) . Consistent with our proposed TTL-tubulin model, mutants of conserved residues positioned at the edge of the N-terminal domain (R29A K31A R32A) inhibited polymerization similarly to wild-type TTL, indicating that they are competent in tubulin binding. The ability to modify the tubulin tail does not seem to affect tubulin sequestration activity, as the catalytic E331Q mutant had comparable activity (Fig. 4b) . Consistent with the tubulin sequestration activity observed in vitro, TTL shows strong product inhibition 42, 47 and our equilibrium sedimentation studies using substrate and product α-tubulin peptides showed that they bound with similar affinities (144 µM for substrate versus 96 µM for product peptide; Supplementary Fig. 7 and Supplementary Methods). We supplemented our in vitro results with studies in living cells. We analyzed microtubule growth rates in human osteosarcoma cells (U2OS line) while manipulating TTL concentrations. We detected and tracked 48 the position of fluorescently tagged plus end-binding protein EB3, which marks the ends of growing microtubules (Fig. 6c) to determine the growth rates of microtubules from time-lapse image series. Overexpression of GFP-TTL at low concentrations reduced the speed of microtubule growth ((average growth rate was 13.04 ± 0.07 µm min −1 (mean ± s.d.; n = 4,225 tracks from four cells) for wild type and 10.86 ± 0.08 µm min −1 for cells expressing GFP-TTL (n = 3,787 from four cells); Fig. 6d,e) , consistent with our in vitro results. Because tyrosination can influence the recruitment of CapGly domain containing plus end-binding proteins (for example, CLIP-170 and p150Glued 14 ) that affect microtubule dynamics, we also investigated the effects of a TTL mutant (E331Q) defective in tubulin tyrosination (Fig. 2d) but not in tubulin binding (Fig. 4b) . Live cell imaging with this mutant showed that it had a similar effect on microtubule growth rates to wild-type TTL (average growth rate was 10.24 ± 0.12 µm min −1 (n = 5,222 from five cells); Fig. 6d,e) , indicating that the reduction in microtubule growth rates was not due to increased tubulin tyrosination.
DISCUSSION
TTL uses a unique bipartite substrate recognition strategy. It makes canonical use of its ATP-grasp ligase active site, which has been tuned evolutionarily to recognize small molecule substrates (such as the end of the α-tubulin tail) and catalyze peptide bond formation. However, in addition, and uniquely among ATP-grasp enzymes, TTL has coopted what is otherwise a homo-oligomerization interface to form a hetero-oligomeric complex with the tubulin body. TTL caps the longitudinal tubulin interface and forms an elongated 1:1 complex with the tubulin heterodimer (Fig. 5) , rendering it unable to incorporate into the microtubule lattice. Consistent with this, TTL inhibited spontaneous tubulin polymerization in vitro and its overexpression decreased microtubule growth rates in vivo (Fig. 6) . This mode of tubulin heterodimer recognition by a protein that can sequester tubulin is previously unknown. Tubulin-sequestering protein stathmin binds two tubulin dimers and caps α-tubulin 49 , whereas centrosomal P4.1-associated protein sequesters a single heterodimer by capping the β-subunit longitudinal interface 50 . Unlike TTL, both these proteins are intrinsically disordered in solution without tubulin 49, 50 . A better understanding of how TTL recognizes the tubulin dimer will require a higher-resolution TTL-tubulin complex structure.
The intracellular concentration of monomeric tubulin is 5-10 µM (ref. 51) . As TTL binds to tubulin with a K d of 1 µM, this implies that TTL is bound to tubulin most of the time in the cell, consistent with earlier observations that TTL isolated from brain extracts copurified with tubulin 22, 41 . TTL acts preferentially on soluble tubulin, and the detyrosination reaction preferentially takes place on microtubules 13 . This creates an asymmetry in the distribution of Tyr-tubulin within the microtubule, with tyrosinated tubulin enriched at the growing plus end (Fig. 7) . The degree of asymmetry depends on the relative rates of tyrosination and detyrosination, and thus has the potential to tune recruitment to the microtubule of proteins sensitive to the tyrosination status, such as CLIP-170 or MCAK 7, 15, 16 .
TTL concentrations vary between wild-type and cancer cells 52 , and among different tissues and developmental stages 19, 53 . The changes in microtubule dynamics and morphology observed in cancer cells could be due not only to downregulation of tubulin tyrosination and effects on the recruitment of microtubule tip-binding proteins, but also to an increase in the polymerization-competent tubulin pool. Studies of TTL concentrations in various cell types together with comprehensive microtubule dynamics analyses are needed to examine the possible role of TTL in affecting the partition between the monomer and polymer pools of tubulin. Further elucidation of the mechanistic details of TTL interaction with tubulin and its effects on microtubule dynamics may provide insight into the origin of drug resistance of tumors with low TTL concentrations.
METhODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/nsmb/. Accession codes. Protein Data Bank: coordinates and structure factors have been deposited for the TTL structure in the apo, ADP and AMPPNP states with accession codes 3TIG, 3TIN and 3TII, respectively. 
